Alexza Pharmaceuticals, Inc. (ALXA) Tops Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts ALXA Hot Sheet
Price: $0.92 --0%
Financial Fact:
Net loss attributable to Alexza common stockholders: -3.02M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Net loss attributable to Alexza common stockholders: -3.02M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) reported Q1 EPS of ($0.04), $0.04 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $1.88 million versus the consensus estimate of $1.3 million.
For earnings history and earnings-related data on Alexza Pharmaceuticals, Inc. (ALXA) click here.
For earnings history and earnings-related data on Alexza Pharmaceuticals, Inc. (ALXA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- BofA maintains underperform ratings on six BDC stocks
- Advance Auto Parts (AAP) PT Lowered to $43 at Truist Securities
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
